IBOGAiN.SE Forum Index
IBOGAiN.SE
Forumet för diskussioner om ibogain och ibogainbehandlingar.
 
 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups 
 RegisterRegister   Log in to check your private messagesLog in to check your private messages   ProfileProfile   Log inLog in 

 IndexIndex   search.php?search_id=newposts&sid=fa6e2820bd422a725f4d4886fad024a5View posts since last visit

Nya artiklar

Post new topic   Reply to topic    IBOGAiN.SE Forum Index -> Ibogain -> Forskning
View previous topic :: View next topic  
Author Message
Operator



Joined: 08 Jun 2006
Posts: 270
Topics: 45

PostPosted: Sun 25 Jun, 2006 07:56    Post subject: Nya artiklar Reply with quote

Med Hypotheses. 2006 May 12;


Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction.

Maas U, Strubelt S.

Scientific African Society, Rohrchenstr. 63, 58452 Witten, Germany.

Ibogaine is the most important alkaloid of the Central African

Iboga-shrub. It is the central drug in Gabonian initiation ceremonies in which it is used to cause a near-death experience. In Western countries it is used in private clinics to treat addiction. However, in the United States and most European countries it is classified as an illegal drug because at least eight persons have died after having taken Ibogaine. These fatalities occurred in most cases several days after ingestion or following the intake of very small doses. There is no conclusive explanation at the present time for these deaths. We hypothesize, that these deaths may be a result of cardiac arrhythmias, caused by a dysregulation of the autonomic nervous system. Ibogaine affects the autonomic nervous system by influencing several neurotransmitter-systems and the fastigial nucleus. The cerebellar nucleus responds to small doses with a stimulation of the sympathetic system, leading to a fight or flight reaction. High doses, however, lead to a vagal dominance: a "feigned death". The risk of cardiac arrhythmias is increased in situations of sympathetic stimulation or coincidence of a high parasympathetic tonus and a left-sided sympathetic stimulation. This could occur under influence of small doses of ibogaine and also at times of exhaustion with a high vagal tonus, when sudden fear reactions could cause a critical left-sided sympathetic stimulation. Gabonian healers prevent these risks by isolating their patients from normal life and by inducing a trance-state with right-hemispheric and vagal dominance for several days.

PMID: 16698188 [PubMed - as supplied by publisher]


Last edited by Operator on Sun 25 Jun, 2006 08:18; edited 2 times in total
Back to top
View user's profile Send private message Visit poster's website
Operator



Joined: 08 Jun 2006
Posts: 270
Topics: 45

PostPosted: Sun 25 Jun, 2006 08:14    Post subject: Reply with quote

Nat Prod Res. 2006 Jul;20(Cool:758-65.

Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine.


Passarella D, Barilli A, Efange SM, Elisabetsky E, Leal MB, Lesma G, Linck VM, Mash DC, Martinelli M, Peretto I, Silvani A, Danieli B.

Dipartimento di Chimica Organica e Industriale, Universita degli Studi di Milano, Via Venezian, 21-20133 Milano, Italy.

Microwave assisted Diels-Alder cycloaddition of 5-Br-N-benzylpyridinone (2) with methyl acrylate is described to gain an easy access to 7-bromo-2-benzyl-3-oxo-2-aza-5 or 6-carbomethoxy bicyclo[2.2.2]oct-7-enes (3)-(6). The preparation of the ibogaine analogue 20-desethyl-(20-endo)-hydroxymethyl-11-demethoxyibogaine (17) is described by stereoselective hydrogenation of the C(7)-C(Cool double bond. Biological evaluation showed an interesting in vitro binding profile toward dopamine transporter, serotonin transporter and opioid receptor systems accompanied by an antiwithdrawal effect in mice for hydroxymethyl 7-indolyl-2-aza-bicyclo[2.2.2]oct-2-ene (14). The simplification of the ibogaine structure appears as a promising approach toward the design of compounds that could reduce the withdrawal symptoms.

PMID: 16753910 [PubMed - in process]

_________________
http://befrielsen.googlepages.com
Back to top
View user's profile Send private message Visit poster's website
Display posts from previous:   
Post new topic   Reply to topic    IBOGAiN.SE Forum Index -> Ibogain -> Forskning All times are GMT + 1 Hour
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum
You cannot attach files in this forum
You cannot download files in this forum


Powered by phpBB © 2001, 2005 phpBB Group